Companies / Arima Genomics
Arima Genomics
United States
Arima Genomics is building DNA-based cancer diagnostics that bring sequence and structure together to find more of what drives disease
Arima Genomics, based in United States, has 2 investors on file, among them Illumina Ventures and Phase Two Ventures. Its site was last checked 13 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Illumina Ventures
42 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (77%), AI & Machine Learning (17%), Cybersecurity (2%).
See Illumina Ventures' full profile · Who invests alongside it
More from Phase Two Ventures
13 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See Phase Two Ventures' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Arima Genomics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Illumina Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/arimagenomics.com/investors
# also
GET /v1/companies/arimagenomics.com
GET /v1/companies/arimagenomics.com/news